Joann Lindenfeld, MD, Professor of Medicine at Vanderbilt University and current President of the Heart Failure Society of America.
Stefan D Anker, MD, Professor for Innovative Clinical Trials, University Medicine Göttingen, Germany, is Councillor of the Board of the European Society of Cardiology.
Josep Rodés-Cabau, MD, Associate Professor of Medicine at Laval University, Quebec, has the most experience implanting the V-Wave Shunt.
All are experienced and widely published academicians, noted clinical trialists and recognized authorities in their specialties.
Ad Statistics
Times Displayed: 112999
Times Visited: 6736 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
“We are fortunate to have a most talented and respected team of Principal Investigators,” said Dr. Neal Eigler, MD and CEO of V-Wave. “With their expert direction, we can develop the scientific basis for interatrial shunting to support applications for regulatory approvals and hasten physician adoption, both in the U.S. and around the world. We believe the V-Wave Shunt has the potential to change the way care is given and fundamentally improve the lives of patients with severe heart failure.”
About V-Wave Ltd.
V-Wave Ltd., is a privately-held medical device company with offices in Israel and the U.S. Venture investors include BRM Group, Pontifax, TriVentures, Pura Vida Investments, BioStar Ventures and strategic investors Edwards Lifesciences and Johnson & Johnson Innovation – JJDC Inc. For further information, visit www.vwavemedical.com.
This press release contains forward-looking statements that involve risks and uncertainties, including statements related to clinical development and potential regulatory approval of V-Wave’s products. All forward-looking statements are based on information available to V-Wave as of the date hereof, and the Company assumes no obligation to update any such forward-looking statements or information. The company's actual results could differ materially from those described in the company's forward-looking statements.
“CAUTION—Investigational Device. Limited by Federal (or United States) Law to Investigational Use.”
Contacts
V-Wave, Ltd.
Neal Eigler, MD
Chief Executive Officer
1-818-629-2164
neal@vwavemedical.com
Back to HCB News
